Barclays PLC Gossamer Bio, Inc. Transaction History

Barclays PLC

$436 Billion
Q2 2025

A detailed history of Barclays PLC transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Barclays PLC holds 338,792 shares of GOSS stock, worth $769,057. This represents 0.0% of its overall portfolio holdings.

Number of Shares

338,792

Previous 338,792 -0.0%

Holding current value

$769,057

Previous $416,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$0.78 - $1.44 $73,079 - $134,916	93,692 Added 38.23%	338,792 $416,000
Q1 2025 May 15, 2025	BUY	$0.85 - $1.53 $208,250 - $374,850	245,000 Added 245000.0%	245,100 $270,000
Q4 2024 Feb 13, 2025	SELL	$0.66 - $1.07 $13,836 - $22,431	-20,964 Reduced 99.53%	100 $0
Q3 2024 Nov 15, 2024	SELL	$0.79 - $1.25 $591,365 - $935,705	-748,564 Reduced 97.26%	21,064 $21,000
Q2 2024 Aug 14, 2024	BUY	$0.51 - $1.27 $392,459 - $977,300	769,528 Added 769528.0%	769,628 $693,000
Q4 2023 Feb 15, 2024	SELL	$0.48 - $1.08 $48 - $108	-100 Reduced 50.0%	100 $0
Q3 2023 Nov 07, 2023	BUY	$0.78 - $1.82 $77 - $180	99 Added 98.02%	200 $0
Q2 2023 Aug 03, 2023	SELL	$0.98 - $1.53 $40,649 - $63,462	-41,479 Reduced 99.76%	101 $0
Q1 2023 May 04, 2023	SELL	$0.96 - $2.92 $1.34 Million - $4.06 Million	-1,391,040 Reduced 97.1%	41,580 $52,000
Q4 2022 Feb 13, 2023	BUY	$1.74 - $12.87 $2.23 Million - $16.5 Million	1,279,971 Added 838.51%	1,432,620 $3.11 Million
Q3 2022 Nov 03, 2022	BUY	$7.21 - $14.88 $1.06 Million - $2.2 Million	147,670 Added 2965.86%	152,649 $1.83 Million
Q2 2022 Aug 12, 2022	BUY	$5.97 - $9.97 $29,724 - $49,640	4,979 New	4,979 $41,000
Q1 2022 May 16, 2022	SELL	$8.44 - $12.49 $611,478 - $904,900	-72,450 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$10.12 - $14.07 $733,194 - $1.02 Million	72,450 New	72,450 $819,000
Q3 2021 Nov 09, 2021	SELL	$7.25 - $13.23 $97,360 - $177,665	-13,429 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$8.0 - $9.75 $103,536 - $126,184	12,942 Added 2657.49%	13,429 $109,000
Q1 2021 May 13, 2021	SELL	$8.63 - $10.94 $235,029 - $297,939	-27,234 Reduced 98.24%	487 $5,000
Q4 2020 Feb 11, 2021	BUY	$8.3 - $13.59 $230,084 - $376,728	27,721 New	27,721 $268,000
Q3 2020 Nov 12, 2020	SELL	$11.3 - $14.75 $595,668 - $777,531	-52,714 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$9.52 - $15.98 $492,612 - $826,885	51,745 Added 5340.04%	52,714 $685,000
Q1 2020 May 13, 2020	BUY	$8.0 - $15.48 $7,680 - $14,860	960 Added 10666.67%	969 $10,000
Q4 2019 Feb 10, 2020	SELL	$14.82 - $26.79 $1.28 Million - $2.31 Million	-86,188 Reduced 99.99%	9 $0
Q3 2019 Nov 14, 2019	BUY	$16.02 - $22.47 $1.38 Million - $1.94 Million	86,197 New	86,197 $1.45 Million
Q2 2019 Aug 14, 2019	SELL	$16.12 - $22.89 $50,584 - $71,828	-3,138 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$17.58 - $23.97 $55,166 - $75,217	3,138 New	3,138 $68,000

Others Institutions Holding GOSS

# of Institutions

142

Shares Held

159M

Call Options Held

2.89M

Put Options Held

130K

View Full List

About Gossamer Bio, Inc.

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $213M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

More about GOSS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account